Medtronic’s Strong Fiscal Year Close Points Toward Market Recovery
The company said its established markets are nearing pre-pandemic sales levels, with ongoing monthly improvement. Jun 01, 2021
Seikagaku Softens Year of Declines with Strong FY 4Q20
The company accelerated its growth to 32% in FY 4Q20 but couldn't completely offset pandemic-related declines for the year. May 18, 2021
Anika Therapeutics Organic Growth Can’t Offset Viscosupplement Declines
The company declined in the mid-single digits due to COVID-related headwinds and inventory stocking declines in its orthobiologics franchise. May 11, 2021
OrthoPediatrics Takes Share to Open 2021
The company grew 31% in the first quarter of 2021, hitting double-digit growth even with ten-year-old products. May 11, 2021
Conformis Near-Term Growth Hinges on Intellectual Property
The company declined in the mid-teens for 1Q21 but hopes to return to product revenue growth above 2019-levels by the end of the year. May 10, 2021
ATEC Marks Tenth Consecutive Quarter of Double-Digit Growth in 1Q21
The company grew 45% in 1Q21 despite surgical volume pressure in January and February as ATEC continues to drive conversion and uptake. May 10, 2021
NuVasive Benefits from International Recovery in 1Q21
The company grew in the mid-single-digits for the first quarter, as recovery in global markets offset some choppiness in the U.S. May 07, 2021
Vericel Raises MACI Guidance on Record First Quarter
The company’s MACI business grew nearly +20% in the first quarter of 2021 as Vericel continues to broaden its surgeon user base. May 07, 2021
Zimmer Biomet Continues Technology Evolution in First Quarter
The company grew in the low single-digits for 1Q21, with important contributions from ROSA and its Signature ONE shoulder planner. May 06, 2021
Globus Medical Takes More Share in First Quarter
The company’s spine business grew over 20% in the first quarter, driven by robotic pull-through, new products and competitive recruiting. May 06, 2021
